KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Return on Equity (2020 - 2025)

Organon has reported Return on Equity over the past 6 years, most recently at 0.23% for Q4 2025.

  • Quarterly results put Return on Equity at 0.23% for Q4 2025, down 157.0% from a year ago — trailing twelve months through Dec 2025 was 0.23% (down 157.0% YoY), and the annual figure for FY2025 was 0.31%, down 399.0%.
  • Return on Equity for Q4 2025 was 0.23% at Organon, down from 0.61% in the prior quarter.
  • Over the last five years, Return on Equity for OGN hit a ceiling of 10.42% in Q2 2024 and a floor of 95.18% in Q1 2024.
  • Median Return on Equity over the past 5 years was 0.0% (2022), compared with a mean of 5.02%.
  • Biggest five-year swings in Return on Equity: plummeted -9496bps in 2024 and later soared 9666bps in 2025.
  • Organon's Return on Equity stood at 0.0% in 2021, then plummeted by -36bps to 0.0% in 2022, then crashed by -107135bps to 3.1% in 2023, then skyrocketed by 158bps to 1.79% in 2024, then tumbled by -87bps to 0.23% in 2025.
  • The last three reported values for Return on Equity were 0.23% (Q4 2025), 0.61% (Q3 2025), and 1.1% (Q2 2025) per Business Quant data.